DIVIDEND ANNOUNCEMENT: Ayala Pharmaceuticals Inc (OTCBB:ADXS) on 02/03/2026 declared a dividend of $0.5200 per share

Ayala Pharmaceuticals Inc (OTCBB:ADXS) on 02/03/2026 declared a dividend of $ 0.5200 per share payable on March 06, 2026 to shareholders of record as of February 03, 2026. Dividend amount recorded is an increase of $ 0.52 from last dividend Paid.

Ayala Pharmaceuticals Inc (OTCBB:ADXS) has paid dividends since 2026, has a current dividend yield of 0.0000000000% and has increased its dividends for 0 successive years.

Ayala Pharmaceuticals Inc's market cap is $ 24,300,810 and has a PE ratio of 0.00. The stock price closed yesterday at $ 0.57 and has a 52 week low/high of $ 0.00 and $ 0.80.

Ayala Pharmaceuticals is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

For more information on Ayala Pharmaceuticals Inc click here.